Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Liminal Biosciences Inc (LMNL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	03-2017	12-2016	09-2016	06-2016	03-2016
Assets
Current Assets
Cash & Cash Equivalents	15,201	20,999	29,918	49,919	25,116
Marketable Securities	N/A	8,355	N/A	N/A	N/A
Receivables	6,062	6,638	5,639	6,892	6,445
Inventories	13,379	10,315	9,518	4,215	4,276
TOTAL	$37,170	$48,530	$47,244	$65,024	$38,929

Non-Current Assets
PPE Net	32,384	31,109	21,994	19,908	16,973
Intangibles	117,543	117,424	113,823	115,108	108,065
Other Non-Current Assets	3,446	3,287	2,078	2,056	1,940
TOTAL	$153,372	$151,820	$137,895	$137,072	$126,978

Total Assets	$190,542	$200,350	$185,140	$202,096	$165,907

Liabilities
Current Liabilities
Short Term Debt	3,874	4,382	N/A	N/A	N/A
Accounts payable and accrued liabilities	14,839	18,000	14,714	8,401	8,712
Other current liabilities	262	261	272	278	283
TOTAL	$19,788	$24,210	$16,017	$9,784	$10,450

Non-Current Liabilities
Long Term Debt	32,696	31,955	31,922	31,287	30,788
Deferred Revenues	814	1,568	1,031	1,105	1,455
Other Non-Current Liabilities	5,539	6,077	3,478	3,206	3,192
TOTAL	$55,351	$55,804	$54,872	$55,436	$54,937

Total Liabilities	$75,139	$80,014	$70,889	$65,220	$65,386

Shareholders' Equity
Common Shares	383,839	362,675	331,815	335,247	266,542
Retained earnings	-340,291	-319,469	-294,915	-277,692	-240,901
Other shareholders' equity	61,205	67,374	69,848	71,794	68,713
TOTAL	$115,403	$120,336	$114,250	$136,876	$100,520

Total Liabilities And Equity	$190,542	$200,350	$185,140	$202,096	$165,907